Pharmacotherapy for microscopic colitis

Pharmacotherapy

Volumn 27, Issue 3, 2007, Pages 425-433

  Wall, Geoffrey C ^a,b   Schirmer, Lori L ^a,b   Page, Michael J ^c  

^a IOWA METHODIST MEDICAL CENTER   (United States)

^b DRAKE UNIVERSITY   (United States)

^c Iowa Inflammatory Bowel Disease Center   (United States)

Author keywords

Chronic diarrhea; Collagenous colitis; Lymphocytic colitis; Microscopic colitis

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID DERIVATIVE; ANTIDIARRHEAL AGENT; AZATHIOPRINE; BISMUTH SALICYLATE; BUDESONIDE; CARBAMAZEPINE; CIMETIDINE; COLESTYRAMINE; CORTICOSTEROID; FLUTAMIDE; GOLD SALT; ISPAGULA; LANSOPRAZOLE; LISINOPRIL; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OMEPRAZOLE; PAROXETINE; PREDNISOLONE; PROTON PUMP INHIBITOR; RANITIDINE; SALAZOSULFAPYRIDINE; SERTRALINE; SIMVASTATIN; TICLOPIDINE;

ANALGESIA; BILE ACID MALABSORPTION; BLACK STOOL; CHRONIC DIARRHEA; COLITIS; COLLAGENOUS COLITIS; COST BENEFIT ANALYSIS; DIARRHEA; DRUG EFFICACY; ELEMENTAL DIET; HAIRY TONGUE; HUMAN; LYMPHOCYTIC COLITIS; MICROSCOPIC COLITIS; QUALITY OF LIFE; REMISSION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; BISMUTH; BUDESONIDE; CHOLESTYRAMINE; COLITIS, MICROSCOPIC; HUMANS; LOPERAMIDE; ORGANOMETALLIC COMPOUNDS; SALICYLATES; TREATMENT OUTCOME;

EID: 33847251151     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.3.425     Document Type: Review

References (39)

1. Pardi DS. Microscopic colitis. Mayo Clin Proc 2003;78:614-17.
2. Protic M, Jojic N, Bojic D, et al. Mechanism of diarrhea in microscopic colitis. World J Gastroenterol 2005;11:5535-9.
3. Lindstrom CG. Collagenous colitis with watery diarrhea: a new entity? Pathol Eur 1976;11:87-9.
4. Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS. Chronic diarrhea of unknown origin. Gastroenterology 1980;78:264-71.
5. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 2004;53:346-50.
6. Pardi DS, Smyrk TC, Kammer P, et al. The epidemiology of microscopic colitis: a population-based study in Olmstead County, Minnesota [abstract]. Gastroenterology 2004;126(suppl 2):A124.
7. Gremse DA, Boudreaux CW, Manci EA. Collagenous colitis in children. Gastroenterology 1993;104:906-9.
8. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002;97:794-801.
9. Abdo AA, Urbanski SJ, Beck PL. Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management. Can J Gastroenterol 2003;17:425-32.
10. Fernandez-Banares F, Salas A, Esteve M, Espinos J, Forne M, Viver JM. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003;98:340-7.
11. Tagkalidis P, Bhathal P, Gibson P. Microscopic colitis. J Gastroenterol Hepatol 2002;17:236-48.
12. Koskela RM, Niemela SE, Kaarttunen TJ, Lehtola JK. Clinical characteristics of collagenous and lymphocytic colitis. Scand J Gastroenterol 2004;9:837-45.
13. Schiller LR. Diagnosis and management of microscopic colitis syndrome. J Clin Gastroenterol 2004;38:S27-30.
14. Barta Z, Mekkel G, Csipo I, et al. Microscopic colitis: a retrospective study of clinical presentation in 53 patients. WorldJ Gastroenterol 2005;11:1351-5.
15. Thomson RD, Lestina LS, Bensen SP Toor A, Maheshwari Y, Ratcliffe NR. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002;97:2908-13.
16. Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005;22:277-84.
17. Byrne MF, McVey G, Royston D, Patchett SE. Association of Clostridium difficile infection with collagenous colitis [letter). J Clin Gastroenterol 2003;36:285.
18. Erim T, Alazmi WM, O'Loughlin CJ, Barkin JS. Digestive diseases and sciences 2003;48:1374-5.
19. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004;53:536-41.
20. Pardi DS, Ramnath VR, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002;97:2829-33.
21. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996;39:846-51.
22. Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci 2001;46:2231-8.
23. Fine K, Ogunji F, Lee E, Lafon G, Tanzi M. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis [abstract]. Gastroenterology 1999;116:A880.
24. Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998;114:29-36.
25. Amaro R, Poniecka A, Rogers AI. Collagenous colitis treated successfully with bismuth subsalicylate. Dig Dis Sci 2000;45:1447-50.
26. Pullan RD, Ganesh S, Mani V, et al. Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut 1993;34:676-9.
27. Munck LK, Kjeldsen J, Philipsen E, Fischer Hansen B. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003;38:606-10.
28. Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122:20-5.
29. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002;123:978-84.
30. Bonderup OK, Hansen JB, Birket-Smith L, Vestergaard V, Teglbjaerg PS, Fallingborg J. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003;52:248-51.
31. Feyen B, Wall GC, Finnerty EP, DeWitt JE, Reyes RS. Meta-analysis: budesonide treatment for collagenous colitis. Aliment Pharmacol Ther 2004;20:745-9.
32. Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005;20:312-16.
33. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg 1995;82:216-22.
34. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115-19.
35. Sandborn WJ, Lofberg R, Feagan BG, Hanauer SB, Campieri M, Greenberg GR. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol 2005;100:1780-7.
36. Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001;120:1483-4.
37. Scheidler MD, Meiselman M. Use of verapamil for the symptomatic treatment of microscopic colitis. J Clin Gastroenterol 2001;32:351-2.
38. Fisher NC, Tutt A, Sim E, Scarpello JH, Green JR. Collagenous colitis responsive to octreotide therapy. J Clin Gastroenterol 1996;23:300-1.
39. Jensen L, Munck LK. Elementary diet reduces diarrhea associated with microscopic colitis. Scand J Gastroenterol 2005;40:1495-6.